Lava Therapeutics NVLVTX
13F holders, Q1 2025 (March 31)20holders −2
6new positions
8sold out
1famous investor
$1.27avg. 13F price*
At the end of Q1 2025, 20 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings, down 2 from Q4 2024. 6 opened new positions and 8 sold out. The largest holders were Redmile Group, LLC ($2.6M), BML Capital Management, LLC ($2.5M) and Sanofi ($2.4M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.6M |
| Exits | 8 | $123K |
All 13F filers, Q4 2024 → Q1 2025: 2,031,093 shares bought and 459,470 shares sold, net +1,571,623 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Redmile Group, LLC | 0.25% | No change | 2,074,372 | $2.6M |
| BML Capital Management, LLC | 2.02% | New | 1,960,610 | $2.5M |
| Sanofi | 1.47% | No change | 1,919,455 | $2.4M |
| Merck & Co., Inc. | 0.89% | No change | 1,149,345 | $1.5M |
| Bruce & Co., Inc. | 0.21% | Reduce -32.4% | 521,874 | $663K |
| Pathway Financial Advisors LLC | 0.02% | No change | 102,500 | $130K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $83K |
| Two Sigma Investments, LP | 0.00% | Add +18.3% | 57,715 | $73K |
| Sphera Funds Management LTD. | 0.02% | Reduce -61.7% | 48,420 | $61K |
| BNP Paribas Financial Markets | 0.00% | Add +8.4% | 45,300 | $58K |
| XTX Topco Ltd | 0.00% | New | 24,307 | $31K |
| Lepercq De Neuflize Asset Management LLC | 0.03% | New | 23,000 | $29K |
| UBS Group AG | 0.00% | Reduce -8.3% | 16,895 | $21K |
| Geode Capital Management, LLC | 0.00% | No change | 16,164 | $21K |
| Morgan Stanley | 0.00% | Add +38.8% | 11,800 | $15K |
| Citadel Advisors | 0.00% | New | 5,023 | $6K |
| JPMorgan Chase & Co. | 0.00% | New | 1,300 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 1,110 | $1K |
| Tsfg, LLC | 0.00% | No change | 400 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 300 | $381 |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.